MDT – Medtronic Plc
Float Short %
1.12
Margin Of Safety %
9
Put/Call OI Ratio
0.43
EPS Next Q Diff
0.33
EPS Last/This Y
0.16
EPS This/Next Y
0.46
Price
101.32
Target Price
111.65
Analyst Recom
2
Performance Q
5.75
Relative Volume
1.43
Beta
0.72
Ticker: MDT
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-26 | MDT | 96.54 | 0.54 | 0.82 | 189384 |
| 2025-12-29 | MDT | 96.14 | 0.54 | 0.34 | 187033 |
| 2025-12-30 | MDT | 96.69 | 0.53 | 0.19 | 188116 |
| 2025-12-31 | MDT | 96.07 | 0.52 | 0.54 | 191244 |
| 2026-01-02 | MDT | 96.05 | 0.52 | 0.30 | 189488 |
| 2026-01-05 | MDT | 97.39 | 0.51 | 0.24 | 184303 |
| 2026-01-06 | MDT | 100.3 | 0.51 | 0.25 | 187755 |
| 2026-01-07 | MDT | 99.75 | 0.50 | 0.31 | 191482 |
| 2026-01-08 | MDT | 98.68 | 0.50 | 0.42 | 193646 |
| 2026-01-09 | MDT | 97.53 | 0.50 | 0.95 | 195658 |
| 2026-01-12 | MDT | 96.91 | 0.53 | 0.32 | 191874 |
| 2026-01-13 | MDT | 96.43 | 0.52 | 0.35 | 197780 |
| 2026-01-14 | MDT | 98.74 | 0.52 | 0.57 | 198734 |
| 2026-01-15 | MDT | 98.96 | 0.53 | 0.39 | 202123 |
| 2026-01-16 | MDT | 96.76 | 0.53 | 0.17 | 203906 |
| 2026-01-20 | MDT | 98.6 | 0.45 | 0.20 | 134760 |
| 2026-01-21 | MDT | 100.28 | 0.44 | 0.21 | 142585 |
| 2026-01-22 | MDT | 101.33 | 0.43 | 0.14 | 144820 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-26 | MDT | 96.53 | -4.0 | 832.1 | 5.65 |
| 2025-12-29 | MDT | 96.14 | -4.0 | 855.4 | 5.65 |
| 2025-12-30 | MDT | 96.68 | -4.0 | 913.7 | 5.65 |
| 2025-12-31 | MDT | 96.08 | -4.0 | 842.2 | 5.65 |
| 2026-01-02 | MDT | 96.04 | -4.0 | 878.3 | 5.65 |
| 2026-01-05 | MDT | 97.39 | -4.0 | 1799.0 | 5.65 |
| 2026-01-06 | MDT | 100.32 | -4.0 | 1913.3 | 5.65 |
| 2026-01-07 | MDT | 99.73 | -4.0 | 1661.5 | 5.65 |
| 2026-01-08 | MDT | 98.68 | -4.0 | 1625.6 | 5.65 |
| 2026-01-09 | MDT | 97.54 | -4.0 | 1620.6 | 5.65 |
| 2026-01-12 | MDT | 96.91 | -4.0 | 1657.6 | 5.65 |
| 2026-01-13 | MDT | 96.43 | -4.0 | 1664.3 | 5.65 |
| 2026-01-14 | MDT | 98.74 | -4.0 | 1868.9 | 5.65 |
| 2026-01-15 | MDT | 98.96 | -4.0 | 1717.7 | 5.65 |
| 2026-01-16 | MDT | 96.76 | -4.0 | 1544.1 | 5.65 |
| 2026-01-20 | MDT | 98.60 | -4.0 | 1834.0 | 5.65 |
| 2026-01-21 | MDT | 100.29 | -4.0 | 1821.3 | 5.65 |
| 2026-01-22 | MDT | 101.32 | -4.0 | 1773.6 | 5.65 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-26 | MDT | -3.17 | 0.60 | 1.18 |
| 2025-12-29 | MDT | -3.17 | 0.60 | 1.18 |
| 2025-12-30 | MDT | -3.17 | 0.60 | 1.18 |
| 2025-12-31 | MDT | -3.17 | 0.60 | 1.18 |
| 2026-01-02 | MDT | -3.17 | 0.60 | 1.18 |
| 2026-01-05 | MDT | -3.17 | 0.63 | 1.18 |
| 2026-01-06 | MDT | -3.17 | 0.63 | 1.18 |
| 2026-01-07 | MDT | -3.17 | 0.63 | 1.18 |
| 2026-01-08 | MDT | -3.17 | 0.63 | 1.18 |
| 2026-01-09 | MDT | -3.17 | 0.63 | 1.18 |
| 2026-01-12 | MDT | -3.14 | 0.64 | 1.18 |
| 2026-01-13 | MDT | -3.17 | 0.64 | 1.12 |
| 2026-01-14 | MDT | -3.17 | 0.64 | 1.12 |
| 2026-01-15 | MDT | -3.17 | 0.64 | 1.12 |
| 2026-01-16 | MDT | -3.17 | 0.64 | 1.12 |
| 2026-01-20 | MDT | -3.17 | 1.73 | 1.12 |
| 2026-01-21 | MDT | -3.17 | 1.73 | 1.12 |
| 2026-01-22 | MDT | -3.17 | 1.73 | 1.12 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.36
Avg. EPS Est. Current Quarter
1.33
Avg. EPS Est. Next Quarter
1.69
Insider Transactions
-3.17
Institutional Transactions
1.73
Beta
0.72
Average Sales Estimate Current Quarter
8894
Average Sales Estimate Next Quarter
9642
Fair Value
110.65
Quality Score
84
Growth Score
87
Sentiment Score
97
Actual DrawDown %
25.4
Max Drawdown 5-Year %
-45.1
Target Price
111.65
P/E
27.38
Forward P/E
16.55
PEG
2.67
P/S
3.74
P/B
2.67
P/Free Cash Flow
24.96
EPS
3.7
Average EPS Est. Cur. Y
5.65
EPS Next Y. (Est.)
6.11
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
13.71
Relative Volume
1.43
Return on Equity vs Sector %
-17.5
Return on Equity vs Industry %
-7.9
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
1773.6
Medtronic plc.Sector: Healthcare
Industry: Medical Devices
Employees: 95000
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
stock quote shares MDT – Medtronic Plc Stock Price stock today
news today MDT – Medtronic Plc stock forecast ,stock prediction 2023 2024 2025
marketwatch MDT – Medtronic Plc yahoo finance google finance
stock history MDT – Medtronic Plc invest stock market
stock prices MDT premarket after hours
ticker MDT fair value insiders trading